Dr. Lorenzo Falchi

Dr. Lorenzo Falchi, MD, is a board-certified medical oncologist and hematologist with over a decade of dedicated focus on the study and treatment of blood diseases, specializing in the care of patients with lymphoma. He practices at Memorial Sloan Kettering Cancer Center, where he is part of a multidisciplinary team of experts committed to developing effective therapies for all types of lymphoma. Dr. Falchi brings extensive experience gained across prestigious institutions to his clinical practice, where his approach centers on providing exceptional care and support for every patient from the first point of contact.

Dr. Falchi is deeply involved in patient-centered research and contributes to one of the largest clinical trial portfolios for lymphoma available at any institution. His research interests are particularly focused on understanding how lymphoma interacts with the immune system, with the goal of harnessing that relationship to develop new immunotherapies that can be used alone or in combination with existing treatments. This work positions him at the forefront of immunotherapy innovation for lymphoma and reflects his broader commitment to advancing treatment options for patients across the full spectrum of the disease.

Central to Dr. Falchi's philosophy is the belief that defeating fear is the first step toward cure. Recognizing that a lymphoma diagnosis can be overwhelming, he prioritizes clear communication, patient education, and the elimination of uncertainty at every visit. He holds firmly to the principle that each person is unique, and his clinical approach is guided by a commitment to personalized care plans that incorporate the most effective and innovative treatments available today. His dedication to both science and compassionate, individualized care defines his practice at MSK.